💨 Abstract
The U.S. approved a new COVID-19 vaccine by Moderna, called mNexspike, as an additional option for high-risk groups. It's designed to be a lower dose and is approved for adults 65 and older and people aged 12 to 64 with health conditions. The FDA's approval was based on a study showing it's safe and at least as effective as Moderna's existing vaccine, Spikevax.
Courtesy: WTOP Staff
Suggested
Fourth man arrested over fires at properties linked to UK Prime Minister Keir Starmer -
Newark airport runway project wraps up early, so when will flight limits ease? -
China blasts US for its computer chip moves and for threatening student visas -
At-home health tests are here. But they aren’t always the best option -
Supreme Court won’t hear challenge to Maryland assault weapons ban -
RFK Jr. says autism ‘destroys’ families. Here’s what those families want you to know -
Pakistan’s anti-polio drive suffers a blow after a northern enclave reports first case in 7 years -
Death toll reaches at least 200 in Nigerian town submerged in floods as rescue efforts halted -
Mexico’s first judicial elections stir controversy and confusion among voters -
Doué’s sensational Champions League performance for PSG launches him into a new dimension -